Familial DICER1 syndrome with thyroid pathology. A series of clinical cases

Thyroid diseases in childhood occupy the second place after obesity in the structure of the general pathology of the endocrine system, eating disorders and metabolic disorders in children in the Russian Federation. Thyroid cancer in children makes up from 1.5 to 3 % of all malignant tumors, and from 8 to 22 % of malignant solid tumors of the head and neck, and the younger the child’s age, the more aggressive the disease proceeds.

Familial forms of thyroid diseases may be associated with geographical features (living in iodine-deficient regions), but may also be part of hereditary syndromes, such as: multiple endocrine neoplasia syndromes (Sipple syndrome, Gorner syndrome, familial medullary thyroid cancer), DICER1 syndrome, Gardner syndrome, Cowden syndrome, McCune–Albright–Braitsev syndrome et al.

This article describes several cases of thyroid pathology associated with DICER1 syndrome.

1. Golubev N.A., Ogryzko E.V., Shelepova E.A., Zalevskaya O.V. The incidence of diseases of the endocrine system, nutritional disorders and metabolic disorders in children within the framework of the national project “Healthcare” of the Russian Federation. Sovremennyye problemy zdravookhraneniya i meditsinskoy statistiki = Modern Problems of Health Care and Medical Statistics. 2019;3:376–89. (In Russ.)].

2. National Guidelines for Pediatric Surgery. Ed. Corresponding member RAS A.Yu. Razumovsky, 2nd edition, revised and expanded. M.: “GEOTAR Media”, 2021. P. 1175. (In Russ.)].

3. Dolgushin B.I., Polyakov V.G., Geliashvili T.M., Gadzhieva E.Kh. Thyroid cancer in children: key recommendations. Pediatriya segodnya = Pediatrics Today. 2022;6(25):6–7. (In Russ.)].

4. Caroleo A.M., De Ioris M.A., Boccuto L., Alessi I., Del Baldo G., Cacchione A., Agolini E., Rinelli M., Serra A., Carai A., Mastronuzzi A. DICER1 Syndrome and Cancer Predisposition: From a Rare Pediatric Tumor to Lifetime Risk. Front Oncol. 2021;10:614541. doi: 10.3389/fonc.2020.614541.

5. González I.A., Stewart D.R., Schultz K.A.P., Field A.P., Hill D.A., Dehner L.P. DICER1 tumor predisposition syndrome: an evolving story initiated with the pleuropulmonary blastoma. Mod Pathol. 2022;35(1):4–22. doi: 10.1038/s41379-021-00905-8.

6. Schultz K.A.P., Stewart D.R., Kamihara J., Bauer A.J., Merideth M.A., Stratton P., Laryssa A.H., Harris A.K., Doros L., Field A., Carr A.G., Dehner L.P., Messinger Y., Ashley D.H. DICER1 Tumor Predisposition. In: Adam M.P., Feldman J., Mirzaa G.M., eds. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle, 1998–2023.

7. Kim J., Field A., Schultz K.A.P., Hill D.A., Stewart D.R. The prevalence of DICER1 pathogenic variation in population databases. Int J Cancer. 2017;141(10):2030–6. doi: 10.1002/ijc.30907.

8. Thunders M., Delahunt B. Gene of the month: DICER1: ruler and controller. J Clin Pathol. 2021;74 (2):69–72. doi: 10.1136/jclinpath-2020-207203.

9. Klein S.D., Martinez-Agosto J.A. Hotspot Mutations in DICER1 Causing GLOW Syndrome-Associated Macrocephaly via Modulation of Specifi c microRNA Populations Result in the Activation of PI3K/ATK/ mTOR Signaling. Microrna. 2020;9(1):70–80. doi: 10.2174/2211536608666190624114424.

10. Darbinyan A., Morotti R., Cai G., Prasad M.L., Christison-Lagay E., Dinauer C., Adeniran A.J. Cytomorphologic features of thyroid disease in patients with DICER1 mutations: A report of cytology-histopathology correlation in 7 patients. Cancer Cytopathol. 2020;128(10):746–56. doi: 10.1002/cncy.22329.

11. Khan N.E., Bauer A.J., Schultz K.A.P., Doros L., Decastro R.M., Ling A., Lodish M.B., Harney L.A., Kase R.G., Carr A.G., Rossi C.T., Field A., Harris A.K., Williams G.M., Dehner L.P., Messinger Y.H., Hill D.A., Stewart D.R. Quantifi cation of Thyroid Cancer and Multinodular Goiter Risk in the DICER1 Syndrome: A Family-Based Cohort Study. J Clin Endocrinol Metab. 2017;102(5):1614–22. doi: 10.1210/jc.2016-2954.

12. Cameselle-Teijeiro J.M., Mete O., Asa S.L., LiVolsi V. Inherited Follicular Epithelial-Derived Thyroid Carcinomas: From Molecular Biology to Histological Correlates. Endocr Pathol. 2021;32(1):77–101. doi: 10.1007/s12022-020-09661-y.

13. Oliver-Petit I., Bertozzi A.I., Grunenwald S., Gambart M., PigeonKerchiche P., Sadoul J.L., Caron P.J., Savagner F. Multinodular goitre is a gateway for molecular testing of DICER1 syndrome. Clin Endocrinol (Oxf). 2019;91(5):669–75. doi: 10.1111/cen.14074.

14. Canberk S., Ferreira J.C., Pereira L., Batısta R., Vieira A.F., Soares P., Sobrinho Simões M., Máximo V. Analyzing the Role of DICER1 Germline Variations in Papillary Thyroid Carcinoma. Eur Thyroid J. 2021;9(6):296–303. doi: 10.1159/000509183.

15. Darbinyan A., Morotti R., Cai G. Cytomorphologic features of thyroid disease in patients with DICER1 mutations: A report of cytologyhistopathology correlation in 7 patients. Cancer Cytopathol. 2020;128(10):746–56. doi: 10.1002/cncy.22329.

16. van der Tuin K., de Kock L., Kamping E.J., Hannema S.E., Pouwels M.M., Niedziela M., van Wezel T., Hes F.J., Jongmans M.C., Foulkes W.D., Morreau H. Clinical and Molecular Characteristics May Alter Treatment Strategies of Thyroid Malignancies in DICER1 Syndrome. J Clin Endocrinol Metab. 2019;104(2):277–84. doi: 10.1210/jc.2018-00774.

17. Peiling Yang S., Ngeow J. Familial non-medullary thyroid cancer: unraveling the genetic maze. Endocr Relat Cancer. 2016;23(12):577–95. doi: 10.1530/ERC-16-0067.

18. Schultz K.A.P., Williams G.M., Kachanov D.Yu., Varfolomeeva S.R., Hill A.D., Dehner L.P., Messinger Y.H. DICER1 syndrome and pleuropulmonary blastoma: a report from the International Pleuropulmonary Blastoma Registry. Rossiyskiy zhurnal detskoy gematologii i onkologii = Russian Journal of Pediatric Hematology and Oncology. 2017;4(4):13–9. (In Russ.)].

19. Altaraihi M., Hansen T.V.O., Santoni-Rugiu E., Rossing M., Rasmussen Å.K., Gerdes A.M., Wadt K. Prevalence of Pathogenic Germline DICER1 Variants in Young Individuals Thyroidectomised Due to Goitre - A National Danish Cohort. Front Endocrinol (Lausanne). 2021;12:727970. doi: 10.3389/fendo.2021.727970.

20. Bakhuizen J.J., Hanson H., van der Tuin K., Lalloo F., Tischkowitz M., Wadt K., Jongmans M.C.J.; SIOPE Host Genome Working Group; CanGene-CanVar Clinical Guideline Working Group; Expert Network Members. Surveillance recommendations for DICER1 pathogenic variant carriers: a report from the SIOPE Host Genome Working Group and CanGene-CanVar Clinical Guideline Working Group. Fam Cancer. 2021;20(4):337–48. doi: 10.1007/s10689-021-00264-y.

21. Niedziela M., Muchantef K., Foulkes W.D. Ultrasound features of multinodular goiter in DICER1 syndrome. Sci Rep. 2022;12(1):15888. doi: 10.1038/s41598-022-19709-0.

22. Nagasaki K., Shibata N., Nyuzuki H., Sasaki S., Ogawa Y., Soda S., Kogai T., Hishinuma A. A Japanese Family with DICER1 Syndrome Found in Childhood-Onset Multinodular Goitre. Horm Res Paediatr. 2020;93(7–8):477–82. doi: 10.1159/000511140.

23. Rio Frio T., Bahubeshi A., Kanellopoulou C., Hamel N., Niedziela M., Sabbaghian N., Pouchet C., Gilbert L., O’Brien P.K., Serfas K., Broderick P., Houlston R.S. DICER1 mutations in familial multinodular goiter with and without ovarian Sertoli–Leydig cell tumors. JAMA. 2011;305(1): 68–77. doi: 10.1001/jama.2010.1910.

24. Foulkes W.D., Bahubeshi A., Hamel N., Pasini B., Asioli S., Baynam G., Choong C.S., Charles A., Frieder R.P., Dishop M.K., Graf N., Ekim M., Bouron-Dal Soglio D., Arseneau J., Young R.H., Sabbaghian N., Srivastava A., Tischkowitz M.D., Priest J.R. Extending the phenotypes associated with DICER1 mutations. Hum Mutat. 2011;32(12):1381–4. doi: 10.1002/humu.21600.

25. Schultz K.A.P., Williams G.M., Kamihara J., Stewart D.R., Harris A.K., Bauer A.J., Turner J., Shah R., Schneider K., Schneider K.W., Carr A.G., Harney L.A., Baldinger S., Frazier A.L., Orbach D., Schneider D.T., Malkin D., Dehner L.P., Messinger Y.H., Hill D.A. DICER1 and Associated Conditions: Identifi cation of At-risk Individuals and Recommended Surveillance Strategies. Clin Cancer Res. 2018;24(10):2251–61. doi: 10.1158/1078-0432.CCR-17-3089.